ArticleJournal of fluorescence2025
Folic Acid-Functionalized Water-Soluble Calixarene for Accurate Identification of Human Breast Cancer Cells.
Article in Journal of fluorescence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Synthesis and characterization of a isothiouronium-calix[4]arene derivative: self-assembly and anticancer activity.Beilstein journal of organic chemistry · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recently, a great interest in the synthesis of various macrocyclic compounds that have the potential to selectively bind to a variety of targets and have the biomedical applications, such as supramolecular biomedical materials, supramolecular diagnostics and self-assembled precursor drugs appear. In this paper, the water-soluble anthracenyl-modified oxacalix[4]arene(AO3) was synthesized by converting four imine groups and ester groups of anthracenyl-modified oxacalix[4]arene (AO1) to amine groups and hydrophilic carboxyl groups respectively via reduction and alkaline hydrolysis reactions. Afterwards, the folic acid was bonded to the AO3 via amidation reaction, and the folic acid-functionalized water-soluble anthracenyl-modified oxacalix[4]arene (FA-AO3) with targeting recognition of cancer cells MCF-7 was prepared. The modification of folic acid made FA-AO3 have an obvious redshift phenomenon by 30 nm and significant increase in fluorescence intensity. When normal cells (HUVEC cells) and cancer cells (MCF-7 cells) were cultured with FA-AO3 respectively, obvious green fluorescence could be observed in cancer cells, while fluorescence phenomenon didn't happen in normal cells, indicating that FA-AO3 had a good specificity to recognize human breast cancer cells. FA-AO3 would have potentially valuable application in early cancer diagnosis and can also be as a drug carrier for specific targeted therapy in the future.
Indexed as
Identifiers
40272690What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.